West Pharmaceutical Services Debt to Equity Ratio 2010-2025 | WST

Current and historical debt to equity ratio values for West Pharmaceutical Services (WST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. West Pharmaceutical Services debt/equity for the three months ending March 31, 2025 was 0.08.
West Pharmaceutical Services Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.94B $2.68B 0.35
2024-12-31 $0.96B $2.68B 0.36
2024-09-30 $0.92B $2.75B 0.34
2024-06-30 $0.91B $2.58B 0.35
2024-03-31 $0.92B $2.68B 0.34
2023-12-31 $0.95B $2.88B 0.33
2023-09-30 $0.89B $2.87B 0.31
2023-06-30 $0.92B $2.75B 0.34
2023-03-31 $0.95B $2.78B 0.34
2022-12-31 $0.93B $2.69B 0.35
2022-09-30 $0.85B $2.47B 0.34
2022-06-30 $0.94B $2.42B 0.39
2022-03-31 $0.97B $2.33B 0.42
2021-12-31 $0.98B $2.34B 0.42
2021-09-30 $0.94B $2.20B 0.43
2021-06-30 $0.90B $2.03B 0.44
2021-03-31 $0.91B $1.83B 0.50
2020-12-31 $0.94B $1.86B 0.51
2020-09-30 $0.86B $1.72B 0.50
2020-06-30 $0.79B $1.61B 0.49
2020-03-31 $0.76B $1.49B 0.51
2019-12-31 $0.77B $1.57B 0.49
2019-09-30 $0.69B $1.49B 0.46
2019-06-30 $0.68B $1.45B 0.47
2019-03-31 $0.67B $1.37B 0.49
2018-12-31 $0.58B $1.40B 0.42
2018-09-30 $0.59B $1.35B 0.44
2018-06-30 $0.59B $1.28B 0.46
2018-03-31 $0.56B $1.31B 0.43
2017-12-31 $0.58B $1.28B 0.46
2017-09-30 $0.61B $1.32B 0.47
2017-06-30 $0.60B $1.24B 0.48
2017-03-31 $0.57B $1.17B 0.48
2016-12-31 $0.60B $1.12B 0.54
2016-09-30 $0.59B $1.14B 0.52
2016-06-30 $0.60B $1.11B 0.54
2016-03-31 $0.59B $1.07B 0.55
2015-12-31 $0.67B $1.02B 0.66
2015-09-30 $0.67B $1.00B 0.67
2015-06-30 $0.67B $0.99B 0.68
2015-03-31 $0.66B $0.94B 0.70
2014-12-31 $0.71B $0.96B 0.75
2014-09-30 $0.70B $0.97B 0.73
2014-06-30 $0.73B $0.97B 0.75
2014-03-31 $0.77B $0.94B 0.83
2013-12-31 $0.77B $0.91B 0.84
2013-09-30 $0.83B $0.84B 0.99
2013-06-30 $0.83B $0.78B 1.06
2013-03-31 $0.83B $0.75B 1.11
2012-12-31 $0.84B $0.73B 1.15
2012-09-30 $0.81B $0.72B 1.13
2012-06-30 $0.78B $0.68B 1.15
2012-03-31 $0.76B $0.70B 1.10
2011-12-31 $0.74B $0.66B 1.14
2011-09-30 $0.71B $0.69B 1.02
2011-06-30 $0.72B $0.70B 1.03
2011-03-31 $0.70B $0.66B 1.06
2010-12-31 $0.67B $0.63B 1.07
2010-09-30 $0.67B $0.63B 1.06
2010-06-30 $0.65B $0.57B 1.14
2010-03-31 $0.67B $0.58B 1.16
2009-12-31 $0.69B $0.58B 1.20
2009-09-30 $0.70B $0.57B 1.23
2009-06-30 $0.69B $0.53B 1.28
2009-03-31 $0.65B $0.49B 1.34
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.094B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.801B 21.68
Becton Dickinson (BDX) United States $49.503B 12.26
Cardinal Health (CAH) United States $36.644B 19.19
Labcorp Holdings (LH) United States $21.758B 17.65
Straumann Holding AG (SAUHY) Switzerland $21.383B 0.00
Cooper (COO) United States $14.283B 18.41
Align Technology (ALGN) United States $13.444B 26.69
Henry Schein (HSIC) United States $8.659B 14.85
Merit Medical Systems (MMSI) United States $5.579B 26.97
DENTSPLY SIRONA (XRAY) United States $3.211B 9.59
CONMED (CNMD) United States $1.762B 13.18
STAAR Surgical (STAA) United States $0.865B 0.00
Lifevantage (LFVN) United States $0.159B 16.43
Pro-Dex (PDEX) United States $0.136B 14.91